Moonlight Therapeutics

Focused on developing safe, effective and patient friendly therapies for those suffering from food allergies.

General Information
Company Name
Moonlight Therapeutics
Founded Year
2017
Location (Offices)
Atlanta, United States +1
Founders / Decision Makers
Number of Employees
5
Industries
Biotechnology, Health Care, Life Sciences
Funding Stage
Series Unknown
Social Media

Moonlight Therapeutics - Company Profile

Moonlight Therapeutics is a biotechnology startup, founded in 2017. The company is dedicated to developing safe, effective, and patient-friendly therapies for individuals afflicted with food allergies. Its initial focus is on creating a treatment specifically designed for children and adults with peanut allergies. Moonlight Therapeutics operates within the industries of biotechnology, healthcare, and life sciences, and is headquartered in the United States. As of now, there is no publicly available information regarding their last investment or the involved investors. With its commitment to addressing a critical health concern and a focus on patient-friendly solutions, Moonlight Therapeutics presents an intriguing prospect for potential venture capital interest.

Funding Rounds & Investors of Moonlight Therapeutics (0)

View All

There is no investment information

Latest News of Moonlight Therapeutics

View All

No recent news or press coverage available for Moonlight Therapeutics.

Similar Companies to Moonlight Therapeutics

View All
Allergy Immunology and Asthma Medical Group - Similar company to Moonlight Therapeutics
Allergy Immunology and Asthma Medical Group Comprehensive care for your allergy, immunology, and asthma needs
ALLERGY AND ASTHMA TREATMENT CENTER, P.C. - Similar company to Moonlight Therapeutics
ALLERGY AND ASTHMA TREATMENT CENTER, P.C. Your trusted partner in comprehensive allergy and asthma care.
Hanimune Therapeutics - Similar company to Moonlight Therapeutics
Hanimune Therapeutics Harnessing the power of natural solutions to prevent and treat food allergies through innovative immune system therapies